(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short interest has increased by 11.54% since the last report, with 8.98 million shares sold short, representing 0.29% of available shares. It would take about 5.96 days to cover these short positions based on current trading volume. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Takeda has a lower short interest compared to its peer group average of 4.37%.
December 25, 2023 | 5:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Takeda Pharmaceutical's short interest has risen, indicating potential bearish sentiment among investors. However, its short interest is below the peer average, which could mitigate negative impact.
While the rise in short interest typically suggests that investors are expecting the price to fall, the fact that Takeda's short interest is below its peer group average could mean that the market sentiment is not as bearish as it might seem. Additionally, the article does not provide any specific negative information about the company that would support a strong bearish case.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80